• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset Realasset
moneycontrol.com
How brokerages are playing Infosys, Tata Motors & Dr Reddys
  • 
	Infosys

	Brokerage: ICICI Direct

	Rating: Hold

	Target: Rs 2650

	Rationale: It expects revenues, EPS to grow 12%, 6% in FY14E translating to revenue. It now value Infosys at 14.8x its CY14E EPS estimate of Rs 179.4 and raises target price to Rs 2,650 versus Rs 2,450 earlier. 

    Infosys Brokerage: ICICI Direct Rating: Hold Target: Rs 2650 Rationale: It expects revenues, EPS to grow 12%, 6% in FY14E translating to revenue. It now value Infosys at 14.8x its CY14E EPS estimate of Rs 179.4 and raises target price to Rs 2,650 versus Rs 2,450 earlier. 

  • 
	Tata Motors

	Brokerage: Citi

	Rating: Buy

	Target: Rs 344

	Rationale: Jaguar land rover's first quarter retail sales grew 10%, driven by jaguar, up more than 30 % year on year, while land rover volume growth was slightly weak. .

    Tata Motors Brokerage: Citi Rating: Buy Target: Rs 344 Rationale: Jaguar land rover's first quarter retail sales grew 10%, driven by jaguar, up more than 30 % year on year, while land rover volume growth was slightly weak. .

  • 
	Infosys

	Brokerage: Jefferies

	Rating: Buy

	Target: Rs 3250

	Rationale: With large deal wins continuing, Jefferies is positive on volume growth and the resultant operating leverage.  

    Infosys Brokerage: Jefferies Rating: Buy Target: Rs 3250 Rationale: With large deal wins continuing, Jefferies is positive on volume growth and the resultant operating leverage.  

  • 
	Dr Reddy’s

	Brokerage: Citi

	Rating: Buy

	Target: Rs 2,125

	Rationale: The approval for Dacogen is positive given the uncertainty over FDA approval timelines & the impact that it can have on street estimates for Dr Reddy's.

    Dr Reddy’s Brokerage: Citi Rating: Buy Target: Rs 2,125 Rationale: The approval for Dacogen is positive given the uncertainty over FDA approval timelines & the impact that it can have on street estimates for Dr Reddy's.

  • 
	Infosys

	Brokerage: Nomura

	Rating: Reduce

	Target: Rs 2,120

	Rationale: It feels consensus expectations for revenue growth will be revised upwards and will likely be above the 10% growth guidance. 

    Infosys Brokerage: Nomura Rating: Reduce Target: Rs 2,120 Rationale: It feels consensus expectations for revenue growth will be revised upwards and will likely be above the 10% growth guidance. 

  • 
	Infosys

	Brokerage: ICICI Direct

	Rating: Hold

	Target: Rs 2650

	Rationale: It expects revenues, EPS to grow 12%, 6% in FY14E translating to revenue. It now value Infosys at 14.8x its CY14E EPS estimate of Rs 179.4 and raises target price to Rs 2,650 versus Rs 2,450 earlier. 
  • 
	Tata Motors

	Brokerage: Citi

	Rating: Buy

	Target: Rs 344

	Rationale: Jaguar land rover's first quarter retail sales grew 10%, driven by jaguar, up more than 30 % year on year, while land rover volume growth was slightly weak. .
  • 
	Infosys

	Brokerage: Jefferies

	Rating: Buy

	Target: Rs 3250

	Rationale: With large deal wins continuing, Jefferies is positive on volume growth and the resultant operating leverage.  
  • 
	Dr Reddy’s

	Brokerage: Citi

	Rating: Buy

	Target: Rs 2,125

	Rationale: The approval for Dacogen is positive given the uncertainty over FDA approval timelines & the impact that it can have on street estimates for Dr Reddy's.
  • 
	Infosys

	Brokerage: Nomura

	Rating: Reduce

	Target: Rs 2,120

	Rationale: It feels consensus expectations for revenue growth will be revised upwards and will likely be above the 10% growth guidance. 

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login